Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies (Q44050973)

29 November 2017

title

Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies (English)

1 reference

29 November 2017

1 reference

11

1 reference

29 November 2017

J Beauté

1

1 reference

29 November 2017

P Levy

2

1 reference

29 November 2017

V Millet

3

1 reference

29 November 2017

M Debré

4

1 reference

29 November 2017

Y Dudoit

5

1 reference

29 November 2017

L Le Mignot

6

1 reference

29 November 2017

A Tajahmady

7

1 reference

29 November 2017

C Thomas

8

1 reference

29 November 2017

F Suarez

9

1 reference

29 November 2017

I Pellier

10

1 reference

29 November 2017

N Aladjidi

12

1 reference

29 November 2017

N Mahlaoui

13

1 reference

29 November 2017

A Fischer

14

1 reference

29 November 2017

French PID study group CEREDIH

15

1 reference

29 November 2017

language of work or name

1 reference

16 December 2009

1 reference

Clinical and Experimental Immunology

29 November 2017

published in

1 reference

29 November 2017

volume

160

1 reference

29 November 2017

issue

2

1 reference

29 November 2017

page(s)

240-245

1 reference

Economic assessment of different modalities of immunoglobulin replacement therapy

29 November 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Adults with X-linked agammaglobulinemia: impact of disease on daily lives, quality of life, educational and socioeconomic status, knowledge of inheritance, and reproductive attitudes

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Infections in 252 patients with common variable immunodeficiency

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiency.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Replacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficiencies

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers.

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs

27 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857947

Pharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insurance

27 August 2018

1 reference

12 December 2020

1 reference

12 December 2020

[Economic evaluation of at home subcutaneous and intravenous immunoglobulin substitution]

1 reference

12 December 2020

Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies

1 reference

12 December 2020

10.1111/J.1365-2249.2009.04079.X

Identifiers

DOI

1 reference

29 November 2017

0 references

1 reference